It was a busy week in the biotech sector with important regulatory and pipeline updates. Among these, Sarepta Therapeutics ...
Marketing and sales expenses increased by €2.8 million in 2024 compared to 2023, as 2024 represented the first full year of ...
Reports Q revenue EUR 165,789 vs EUR 63, 089 last year. Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx (IFRX), ...
Topline data from Phase 2 LOTUS Trial of AVTX-009 for the treatment of hidradenitis suppurativa expected in 2026 Appointed Jennifer Riley as ...
Topline data from Phase 2 LOTUS Trial of AVTX-009 for the treatment of hidradenitis suppurativa expected in 2026 Appointed Jennifer Riley as Chief Strategy Officer Cash on hand of approximately $135 ...
The annual meeting of the American Academy of Dermatology was held from March 7 to 11 in Orlando, Florida, and attracted ...
A recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...